{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:57:15Z","timestamp":1790546235182,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","award":["cstc2021jcyj-msxmX1089"],"award-info":[{"award-number":["cstc2021jcyj-msxmX1089"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37112","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T13:00:06Z","timestamp":1724850006000},"page":"e37112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety profile of levonorgestrel intrauterine system: Analysis of spontaneous reports submitted to FAERS"],"prefix":"10.1016","volume":"10","author":[{"given":"Lin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.heliyon.2024.e37112_bib1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/01.ogx.0000175805.90122.af","article-title":"Contraceptive and therapeutic effects of the levonorgestrel intrauterine system: an overview","volume":"60","author":"Jensen","year":"2005","journal-title":"Obstet. Gynecol. Surv."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e37112_bib2","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1600-0412.2011.01256.x","article-title":"Recent developments in the clinical use of the levonorgestrel-releasing intrauterine system","volume":"90","author":"Gemzell-Danielsson","year":"2011","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37112_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.12891\/ceog1826.2015","article-title":"Levonorgestrel-releasing intrauterine device use as an alternative to surgical therapy for uterine leiomyoma","volume":"42","author":"Senol","year":"2015","journal-title":"Clin. Exp. Obstet. Gynecol."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e37112_bib4","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37112_bib5","first-page":"129","article-title":"The role of levonorgestrel intrauterine systems in the treatment of symptomatic fibroids","volume":"16","author":"Wrona","year":"2017","journal-title":"Prz Menopauzalny"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37112_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.contraception.2015.08.019","article-title":"Transmural migration and perforation of a levonorgestrel intrauterine system: a case report and review of the literature","volume":"93","author":"Ferguson","year":"2016","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37112_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/2042098615622316","article-title":"Risk of intracranial hypertension with intrauterine levonorgestrel","volume":"7","author":"Friedman","year":"2016","journal-title":"Ther Adv Drug Saf."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37112_bib9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/aogs.13564","article-title":"Levonorgestrel intrauterine contraceptive systems (13.5 mg and 52 mg) and risk of ectopic pregnancy","volume":"98","author":"Graner","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37112_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.contraception.2015.01.007","article-title":"Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices","volume":"91","author":"Heinemann","year":"2015","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37112_bib11","doi-asserted-by":"crossref","first-page":"599.e1","DOI":"10.1016\/j.ajog.2016.05.017","article-title":"A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement","volume":"215","author":"Turok","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37112_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e14733","article-title":"Levonorgestrel intrauterine system and breast cancer risk: an updated systematic review and meta-analysis of observational studies","volume":"9","author":"Heting","year":"2023","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37112_bib13","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/aogs.13817","article-title":"Levonorgestrel-releasing intrauterine system and breast cancer risk: a systematic review and meta-analysis","volume":"99","author":"Conz","year":"2020","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37112_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nbt.2113","article-title":"OpenVigil--free eyeballs on AERS pharmacovigilance data","volume":"30","author":"B\u00f6hm","year":"2012","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37112_bib15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2165\/00002018-200730070-00009","article-title":"Standardised MedDRA queries: their role in signal detection","volume":"30","author":"Mozzicato","year":"2007","journal-title":"Drug Saf."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37112_bib16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2165\/00002018-200730070-00009","article-title":"Standardised MedDRA queries: their role in signal detection","volume":"30","author":"Ahmed","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.heliyon.2024.e37112_bib17","doi-asserted-by":"crossref","unstructured":"Ooba N, Kubota K. Selected control events and reporting odds ratio in signal detection methodology. PHARMACOEPIDEM DR S, 19 (11), 1159-1165. https:\/\/doi.org\/10.1002\/pds.2014.","DOI":"10.1002\/pds.2014"},{"key":"10.1016\/j.heliyon.2024.e37112_bib18","doi-asserted-by":"crossref","unstructured":"Poluzzi E, Raschi E, Moretti U, et al. Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS). PHARMACOEPIDEM DR S, 18 (6), 512-518. https:\/\/doi.org\/10.1002\/pds.1746.","DOI":"10.1002\/pds.1746"},{"key":"10.1016\/j.heliyon.2024.e37112_bib19","doi-asserted-by":"crossref","unstructured":"Sakaeda T, Tamon A, Kadoyama K, et al. Data mining of the public version of the FDA Adverse Event Reporting System. Int. J. Med. Sci. 2013;10(7):796\u2013803. https:\/\/doi.org\/10.7150\/ijms.6048.","DOI":"10.7150\/ijms.6048"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37112_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa1204724","article-title":"Levonorgestrel intrauterine system versus medical therapy for menorrhagia","volume":"368","author":"Gupta","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e37112_bib21","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/AOG.0000000000000475","article-title":"Association of age and parity with intrauterine device expulsion","volume":"124","author":"Madden","year":"2014","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37112_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijgo.2010.10.013","article-title":"Length of the endometrial cavity and intrauterine contraceptive device expulsion","volume":"113","author":"Bahamondes","year":"2011","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37112_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/11598960-000000000-00000","article-title":"The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefifit-risk review","volume":"72","author":"Kaunitz","year":"2012","journal-title":"Drugs"},{"issue":"6 Suppl","key":"10.1016\/j.heliyon.2024.e37112_bib24","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.contraception.2006.12.005","article-title":"Copper intrauterine device use by nulliparous women: review of side effects","volume":"75","author":"Hubacher","year":"2007","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37112_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijgo.2011.07.031","article-title":"Effificacy of the levonorgestrelreleasing intrauterine system in uterine leiomyoma","volume":"116","author":"Kriplani","year":"2012","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37112_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijgo.2014.02.017","article-title":"Factors affecting the spontaneous expulsion of the levonorgestrel-releasing intrauterine system","volume":"126","author":"Youm","year":"2014","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"13","key":"10.1016\/j.heliyon.2024.e37112_bib27","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/1471-0528.14813","article-title":"Expulsions and adverse events following immediate and later insertion of a levonorgestrel-releasing intrauterine system after medical termination of late first- and second-trimester pregnancy: a randomised controlled trial","volume":"124","author":"Korjamo","year":"2017","journal-title":"BJOG An Int. J. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37112_bib28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJMcp0810384","article-title":"Clinical practice. Ectopic pregnancy","volume":"361","author":"Barnhart","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37112_bib29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.contraception.2015.01.011","article-title":"Comparative contraceptive effectiveness of levonorgestrel releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices","volume":"91","author":"Heinemann","year":"2015","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37112_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJMcp0810384","article-title":"Clinical practice. Ectopic pregnancy","volume":"361","author":"Barnhart","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e37112_bib31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0140-6736(92)91904-M","article-title":"Intrauterine devices and pelvic inflammatory disease: an international perspective","volume":"339","author":"Farley","year":"1992","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37112_bib32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0010-7824(94)90109-0","article-title":"Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial","volume":"49","author":"Andersson","year":"1994","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37112_bib33","doi-asserted-by":"crossref","first-page":"599.e1","DOI":"10.1016\/j.ajog.2016.05.017","article-title":"A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement","volume":"215","author":"Turok","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37112_bib34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jog.13828","article-title":"Safety and efficacy of a 52-mg levonorgestrel-releasing intrauterine system in women with cardiovascular disease","volume":"45","author":"Ueda","year":"2019","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37112_bib35","doi-asserted-by":"crossref","first-page":"873.e1","DOI":"10.1016\/j.ajog.2022.09.007","article-title":"Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial","volume":"227","author":"Jensen","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"13","key":"10.1016\/j.heliyon.2024.e37112_bib36","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","article-title":"Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children","volume":"81","author":"Friedman","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37112_bib37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00701-016-3050-7","article-title":"An update on idiopathic intracranial hypertension","volume":"159","author":"Portelli","year":"2017","journal-title":"Acta Neurochir."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37112_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ncl.2016.08.004","article-title":"Update on idiopathic intracranial hypertension","volume":"35","author":"Wall","year":"2017","journal-title":"Neurol. Clin."},{"issue":"25","key":"10.1016\/j.heliyon.2024.e37112_bib39","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJM199506223322519","article-title":"Levonorgestrel implants and intracranial hypertension","volume":"332","author":"Alder","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37112_bib40","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1111\/ene.14480","article-title":"Pseudotumor cerebri syndrome with different types of hormonal contraceptives in women of child-bearing age","volume":"27","author":"Etminan","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37112_bib41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/01658107.2017.1304425","article-title":"An estimation of the risk of pseudotumor cerebri among users of the levonorgestrel intrauterine device","volume":"41","author":"Valenzuela","year":"2017","journal-title":"Neuro Ophthalmol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37112_bib42","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/aogs.13817","article-title":"Levonorgestrel-releasing intrauterine system and breast cancer risk: a systematic review and meta-analysis","volume":"99","author":"Conz","year":"2020","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37112_bib43","first-page":"35","article-title":"Epidemiological risk factors for breast cancer--a review","volume":"8","author":"Okobia","year":"2005","journal-title":"Niger. J. Clin. Pract."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37112_bib44","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clbc.2021.03.013","article-title":"Meta-analysis of breast cancer risk in levonorgestrel-releasing intrauterine system users","volume":"21","author":"Silva","year":"2021","journal-title":"Clin. Breast Cancer"},{"issue":"10354","key":"10.1016\/j.heliyon.2024.e37112_bib45","first-page":"732","article-title":"Intrauterine device-related uterine perforation incidence and risk (APEX-IUD): a large multisite cohort study [published correction appears in","volume":"400","author":"Reed","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e37112_bib46","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/humrep\/des246","article-title":"Intrauterine contraception: incidence and factors associated with uterine perforation--a population-based study","volume":"27","author":"Kaislasuo","year":"2012","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37112_bib47","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/humrep\/det074","article-title":"Uterine perforation caused by intrauterine devices: clinical course and treatment","volume":"28","author":"Kaislasuo","year":"2013","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37112_bib48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.contraception.2005.08.013","article-title":"Uterine perforation in women using a levonorgestrel-releasing intrauterine system","volume":"73","author":"Van Houdenhoven","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.heliyon.2024.e37112_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.psyneuen.2017.02.025","article-title":"The levonorgestrel-releasing intrauterine device potentiates stress reactivity","volume":"80","author":"Aleknaviciute","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37112_bib50","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jog.13828","article-title":"Safety and efficacy of a 52-mg levonorgestrel-releasing intrauterine system in women with cardiovascular disease","volume":"45","author":"Ueda","year":"2019","journal-title":"J. Obstet. Gynaecol. Res."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402413143X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402413143X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:10:23Z","timestamp":1790543423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402413143X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":49,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S240584402413143X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37112","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety profile of levonorgestrel intrauterine system: Analysis of spontaneous reports submitted to FAERS","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37112"}}